GLP-1 therapy is not a standalone solution and works best as part of a comprehensive, medically supervised program
Without coverage: Wegovy and Zepbound typically cost around $1,000 to $1,400 per month Ozempic and Mounjaro fall into a similar price range, though they are often prescribed for diabetes Older medications like phentermine and metformin are far more affordablesometimes as low as $10 to $50 per monthbut coverage and availability still vary Discounts and Savings Programs For patients paying out-of-pocket, there may be opportunities to reduce costs: Pharmacy discount programs like GoodRx or SingleCare can lower retail prices on certain medicationsbut these discounts typically dont apply to brand-name GLP-1s unless you have commercial insurance Manufacturer savings cards may reduce your co-pay if you have private insurance (these do not apply to Medicare or Medicaid) Patient assistance programs may be available for those who meet income eligibility requirements What About Compounded Medications
[DOI] [PubMed] [Google Scholar] 67.Fezza R, Rains B, Fezza T, et al
You need to actually follow the program for 16 weeks, not have used competing medications, and actively verify your weight through documentation
However, the interplay between melatonin and these novel cell death pathways in the context of ovarian aging remains largely unexplored
Current 2026 approved GLP-1 RA medications include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
